Treatment of Acne Keloidalis Nuchae (Razor Bumps Behind the Neck) Using UV Light Therapy

This study has been completed.
Sponsor:
Collaborator:
Skin of Color Society
Information provided by:
Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT01328080
First received: March 31, 2011
Last updated: September 19, 2012
Last verified: August 2012

March 31, 2011
September 19, 2012
February 2011
August 2012   (final data collection date for primary outcome measure)
Resolution of AKN [ Time Frame: 16 weeks ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01328080 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Treatment of Acne Keloidalis Nuchae (Razor Bumps Behind the Neck) Using UV Light Therapy
Improving Acne Keloidalis Nuchae by Inducing Matrix Metalloproteinases in Vivo Using Targeted Ultraviolet-B Irradiation

This study is being done to evaluate the effect of targeted UV-B (a component of sunlight) on the treatment of acne keloidalis nuchae (AKN, or razor bumps on the back of the neck). The investigators believe targeted UV-B is a safe and effective way to reduce the appearance of AKN.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment
Acne Keloidalis Nuchae
Radiation: Targeted UV-B
Daavlin Lumera phototherapy device (290-320 nm), dosed by patients' individual minimal erythema dose (MED)
Experimental: Targeted UV-B
Intervention: Radiation: Targeted UV-B
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
8
August 2012
August 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • age 18 or over
  • male gender
  • African-American or other black ethnicity
  • current diagnosis of acne keloidalis nuchae (razor bumps on back of neck)

Exclusion Criteria:

  • allergy to lidocaine or numbing medicine
  • history of increased sensitivity to sunlight, lupus, or porphyria
  • current use of a drug that increases sensitivity to sunlight
Male
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01328080
NA_00035842
No
Ginette Hinds, M.D., Johns Hopkins University Dept. of Dermatology
Johns Hopkins University
Skin of Color Society
Not Provided
Johns Hopkins University
August 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP